Product Highlight - Semglee
07 Apr 2022
Active ingredient: Insulin glargine.
Indication: DM in adults, adolescents & childn ≥2 yr.
Dosage & Administration: SC Individualized dose. Administer once daily at the same time each day. Switch from bid NPH insulin to Semglee Reduce 20-30% of daily dose of basal insulin during the 1st wk of treatment. Switch from insulin glargine 300 u/mL to Semglee Reduce dose by approx 20%.
VIATRIS (THAILAND) LIMITED
No. 88 The Parq Building, 11th Floor, Ratchadapisek Road,
Klongtoey Subdistrict, Klongtoey District,
Bangkok, Thailand 10110
Tel: (+66) 2339 0630 • Fax: (+66) 2339 0631
Indication: DM in adults, adolescents & childn ≥2 yr.
Dosage & Administration: SC Individualized dose. Administer once daily at the same time each day. Switch from bid NPH insulin to Semglee Reduce 20-30% of daily dose of basal insulin during the 1st wk of treatment. Switch from insulin glargine 300 u/mL to Semglee Reduce dose by approx 20%.
VIATRIS (THAILAND) LIMITED
No. 88 The Parq Building, 11th Floor, Ratchadapisek Road,
Klongtoey Subdistrict, Klongtoey District,
Bangkok, Thailand 10110
Tel: (+66) 2339 0630 • Fax: (+66) 2339 0631
